Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Annals of the Rheumatic Diseases|February 14, 2012
Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritisPeter C Grayson, Kathleen Maksimowicz-McKinnon, Tiffany M Clark, et al.
Arthritis and Rheumatism|April 13, 2011
Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term followup of a multicenter longitudinal cohortFrancisco Silva, Philip Seo, Darrell R Schroeder, et al.
The Journal of Rheumatology|April 17, 2015
Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort StudyTanaz A Kermani, Kenneth J Warrington, David Cuthbertson, et al.
Annals of the Rheumatic Diseases|September 22, 2022
Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL SurveillanceChristina Charles-Schoeman, Maya H Buch, Maxime Dougados, et al.
Arthritis and Rheumatism|June 30, 2005
Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET)Philip Seo, Yuan-I Min, Janet T Holbrook, et al.
The American Journal of Medicine|December 28, 2005
Herpes zoster in immunocompromised patients: incidence, timing, and risk factorsPeter K Wung, Janet T Holbrook, Gary S Hoffman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 14, 2024
Risk of Venous Thromboembolism With Tofacitinib Versus Tumor Necrosis Factor Inhibitors in Cardiovascular Risk-Enriched Rheumatoid Arthritis PatientsChristina Charles-Schoeman, Roy Fleischmann, Eduardo Mysler, et al.
The Journal of Rheumatology|April 3, 2016
The Birmingham Vasculitis Activity Score as a Measure of Disease Activity in Patients with Giant Cell ArteritisTanaz A Kermani, David Cuthbertson, Simon Carette, et al.
Annals of Internal Medicine|November 3, 2007
Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosisJavier D Finkielman, Peter A Merkel, Darrell Schroeder, et al.
Arthritis Care & Research|December 1, 2011
Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's)Megan E B Clowse, Susannah C Copland, Tsung-Cheng Hsieh, et al.
Pageof 10